- Country: Belarus
- Summary: 24-8 Palivizumab Drug (registered Drugs)
- BYT Ref No: 112057791
- Deadline: 03 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: BYN 8123904
- Notice Type: Tender
- Document Ref. No.: AU20241218324744
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- 24-8 Palivizumab drug (registered drugs)
- Documents:
proekt_dogovor_rezidenty_2024_dlya_EA_posrednik_VF.doc
proekt_dogovor_rezidenty_2024_dlya_EA_proizvoditel_VF.doc
proekt_kontrakta_dlya_nerezidentov_2024_ZAREG_dlya_EA_VF.doc
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN24-8 Palivizumab Drug (registered Drugs) - Belarus Tender
The VITEBSK UNIVERSITY "PHARMACY", a Government sector organization in Belarus, has announced a new tender for 24-8 Palivizumab Drug (registered Drugs). This tender is published on BelarusTenders under BYT Ref No: 112057791 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-03.
The estimated tender value is BYN 8123904, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
